|
| Press Releases |
|
 |
|
| Monday, January 18, 2021 |
|
|
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China |
| SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the first healthy subject was successfully dosed in the Phase I clinical trial of SN1011 more info >> |
|
| Monday, November 23, 2020 |
|
|
SinoMab Commenced Construction of its China Headquarters |
| SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Thursday, July 23, 2020 |
|
|
SinoMab entered into Strategic Collaboration with D2M |
| SinoMab BioScience Limited ("SinoMab" of the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Wednesday, June 10, 2020 |
|
|
SinoMab Announces Clinical Results on its First-in-target SM03 at EULAR 2020 Congress |
| SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Friday, January 10, 2020 |
|
|
SinoMab Granted the "Most Popular Newly Listed Company" Award |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen. more info >> |
|
| Wednesday, November 20, 2019 |
|
|
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate SM03 Phase III Clinical Trial for the Treatment RA |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce its latest progress of SM03 phase III clinical trial for the treatment rheumatoid arthritis. more info >> |
|
| Wednesday, October 30, 2019 |
|
|
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
LANGHAM BEAUTY Green Vitality 
Nov 27, 2024 22:05 HKT/SGT
|
|
|
GMG's THERMAL-XR(R) Awarded Product of the Year at the AIRAH 2024 Awards
Nov 27, 2024 21:59 HKT/SGT
|
|
|
EdgePoint Infrastructure Inks Strategic Partnership with CelcomDigi to expand connectivity in Malaysia at TowerXchange Meet Up Asia 2024
Nov 27, 2024 21:30 HKT/SGT
|
|
|
Step Into the World of Jean-Michel Basquiat
Nov 27, 2024 20:00 HKT/SGT
|
|
|
Expert Systems Announces FY25 Interim Results
Nov 27, 2024 19:50 HKT/SGT
|
|
|
Kingworld-Longde Life and Health Industrial Park Grand Opening
Nov 27, 2024 19:40 HKT/SGT
|
|
|
Swire Coca-Cola Hong Kong Leverages SAP S/4HANA and SAP Services to Drive Digital Transformation
Nov 27, 2024 19:30 HKT/SGT
|
|
|
Cropmate Berhad IPO Oversubscribed by 84.88 Times
Nov 27, 2024 18:00 HKT/SGT
|
|
|
Quranium Launches QSafe Wallet with Core Layer (L1) Testnet: The Uncrackable Solution for Blockchain Security
Nov 27, 2024 17:20 HKT/SGT
|
|
|
Survey: New Opportunities in Cross-border E-commerce
Nov 27, 2024 17:11 HKT/SGT
|
|
|
Quranium Node Pre-sale Unveiled: Be Part of the Quantum-Uncrackable Revolution
Nov 27, 2024 17:00 HKT/SGT
|
|
|
Q2 Metals Significantly Expands the Cisco Lithium Property in James Bay, Quebec, Canada
Nov 27, 2024 16:30 HKT/SGT
|
|
|
SF Holding successfully listed in Hong Kong
Nov 27, 2024 16:19 HKT/SGT
|
|
|
Ching Lee Holdings (3728.HK) Reports Significant Growth in Interim Results for 2024
Nov 27, 2024 10:32 HKT/SGT
|
|
|
Genetec maintains stable and profitable performance on a lower Q1FY2025 revenue
Nov 27, 2024 10:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
